1. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery.
- Author
-
Xu Y, Ma S, Cui H, Chen J, Xu S, Gong F, Golubovic A, Zhou M, Wang KC, Varley A, Lu RXZ, Wang B, and Li B
- Subjects
- Humans, Lipids chemistry, Gene Transfer Techniques, COVID-19 Vaccines, mRNA Vaccines, Cell Line, Combinatorial Chemistry Techniques, Liposomes, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Messenger administration & dosage, Deep Learning, SARS-CoV-2 genetics, Nanoparticles chemistry, COVID-19
- Abstract
Ionizable lipid nanoparticles (LNPs) are seeing widespread use in mRNA delivery, notably in SARS-CoV-2 mRNA vaccines. However, the expansion of mRNA therapies beyond COVID-19 is impeded by the absence of LNPs tailored for diverse cell types. In this study, we present the AI-Guided Ionizable Lipid Engineering (AGILE) platform, a synergistic combination of deep learning and combinatorial chemistry. AGILE streamlines ionizable lipid development with efficient library design, in silico lipid screening via deep neural networks, and adaptability to diverse cell lines. Using AGILE, we rapidly design, synthesize, and evaluate ionizable lipids for mRNA delivery, selecting from a vast library. Intriguingly, AGILE reveals cell-specific preferences for ionizable lipids, indicating tailoring for optimal delivery to varying cell types. These highlight AGILE's potential in expediting the development of customized LNPs, addressing the complex needs of mRNA delivery in clinical practice, thereby broadening the scope and efficacy of mRNA therapies., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF